Ignite Creation Date:
2024-05-06 @ 2:58 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04489433
Status:
AVAILABLE
Last Update Posted:
2024-02-08
First Post:
2020-07-23
Brief Title:
Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma
Sponsor:
Organization:
Novartis